Guardanthealth Eclipse Blood Test

Listing Websites about Guardanthealth Eclipse Blood Test

Filter Type:

Guardant Health announces positive results from pivotal ECLIPSE …

(7 days ago) WEB- The test demonstrated 83% sensitivity for the detection of colorectal cancer with specificity of 90% - Results pave the way for first potential FDA-approved …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/default.aspx

Category:  Cancer Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(9 days ago) WEBECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://www.businesswire.com/news/home/20221215006055/en/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer

Category:  Health Show Health

Guardant Health Initiates ECLIPSE Pivotal Study for its LUNAR-2 …

(2 days ago) WEBGuardant Health, Inc. has initiated the ECLIPSE trial, a 10,000-patient registrational study to evaluate the performance of its LUNAR-2 blood test to detect colorectal cancer …

https://www.guardanthealthamea.com/guardant-health-initiates-eclipse-pivotal-study-for-its-lunar-2-blood-test-for-colorectal-cancer-screening/

Category:  Cancer Show Health

A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening

(1 days ago) WEBThe ECLIPSE (Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode) study was designed to evaluate the performance of the cfDNA …

https://www.nejm.org/doi/full/10.1056/NEJMoa2304714

Category:  Health Show Health

Home - GuardantHealth

(7 days ago) WEBOver 500,000 of our blood tests have been performed by 12,000 doctors to date. Our commercially available tests help inform treatment decisions for patients with advanced cancer, monitor treatment response, detect …

https://guardanthealth.com/

Category:  Cancer Show Health

Guardant Health ECLIPSE Study Data Demonstrating Efficacy of …

(Just Now) WEBECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://finance.yahoo.com/news/guardant-health-eclipse-study-data-210000399.html

Category:  Health Show Health

Home Guardant Health Blood-Based Screening

(2 days ago) WEBGuardant Health has advanced our technology to include screening for early CRC detection 5,9. We are dedicated to supporting patients with cancer across the continuum of care. …

https://bloodbasedscreening.com/

Category:  Cancer Show Health

FAQs Guardant Health Blood-Based Screening

(7 days ago) WEBThe ECLIPSE clinical study, published in the New England Journal of Medicine, was a large-scale colorectal cancer screening study that evaluated the performance of Shield, …

https://bloodbasedscreening.com/faqs/

Category:  Cancer,  Medicine Show Health

Guardant Health ECLIPSE Study Data Demonstrating Efficacy

(3 days ago) WEBECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://www.morningstar.com/news/business-wire/20240313547689/guardant-health-eclipse-study-data-demonstrating-efficacy-of-shield-blood-based-test-for-colorectal-cancer-screening-to-be-published-in-the-new-england-journal-of-medicine

Category:  Health Show Health

Blood-Based DNA Test Shows Sensitivity of 83% for Colorectal …

(5 days ago) WEBA new cell-free DNA blood based screening test demonstrated sensitivity of 83% for colorectal cancer (CRC), 90% specificity for advanced neoplasia, and 13% …

https://www.patientcareonline.com/view/blood-based-dna-test-shows-sensitivity-of-83-for-colorectal-cancer

Category:  Cancer Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(Just Now) WEBThe test demonstrated 83% sensitivity for the detection of colorectal cancer with specificity of 90%

https://discover.guardanthealth.com/2022/12/15/guardant-health-announces-positive-results-from-pivotal-eclipse-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/

Category:  Cancer Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(5 days ago) WEBPALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today positive results from …

https://www.biospace.com/article/releases/guardant-health-announces-positive-results-from-pivotal-eclipse-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/

Category:  Health Show Health

FDA Advisory Panel Review of Guardant Health’s Shield™ Blood …

(Just Now) WEBPALO ALTO, Calif., April 22, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the …

https://finance.yahoo.com/news/fda-advisory-panel-review-guardant-125200837.html

Category:  Health Show Health

Filter Type: